Accumulated p53 protein and UVA protection level of sunscreens

Photodermatology Photoimmunology and Photomedicine

Volumn 16, Issue 1, 2000, Pages 3-9

  Seité, Sophie ^a   Moyal, D ^a   Verdier, M P ^a   Hourseau, C ^a   Fourtanier, A ^a  

^a L ORÉAL RECHERCHE   (France)

Author keywords

Immunohistochemistry; P53; Persistent pigment darkening; Protection factor; Solar simulated radiation; Sunscreens; UVA

Indexed keywords

AVOBENZONE; PROTEIN P53; SULISOBENZONE; SUNSCREEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; EPIDERMIS; ERYTHEMA; HISTOPATHOLOGY; HUMAN; HUMAN EXPERIMENT; IMMUNOHISTOCHEMISTRY; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION PROTECTION; SKIN BIOPSY; SKIN DEFECT; SKIN PIGMENTATION; ULTRAVIOLET A RADIATION;

EID: 0033951836     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0781.2000.160103.x     Document Type: Article

References (18)

1. Diffey BL. Population exposure to solar UVA radiation. Eur J Dermatol 1996: 6: 221-222.
2. Gilchrest BA. Photodamage. New York: Blackwell, 1995.
3. Lavker RM, Gerberick GF, Veres DA, Irwin CJ, Kaidbey KH. Cumulative effects from repeated exposures to suberythemal doses of UVB and UVA in human skin. J Am Acad Dermatol 1995: 32: 53-62.
4. Seité S, Moyal D, Richard S et al. Mexoryl SX: A broad absorption UVA filter protects human skin from the effects of repeated suberythemal doses of UVA. J Photochem Photobiol B 1998: 44: 69-76.
5. Hall PA, McKee PH, du Menage P, Dover R, Lane DP. High levels of p53 protein in UV-irradiated normal human skin. Oncogene 1993: 8: 203-207.
6. Jonason AS, Kunala S, Price GJ et al. Frequent clones of p53-mutated keratinocytes in normal human skin. Proc Natl Acad Sci USA 1996: 93: 14025-14029.
7. Ponten F, Berne B, Ren ZP, Nister M, Ponten J. Ultraviolet light induces expression of p53 and p21 in human skin: effect of sunscreen and constitutive p21 expression in skin appendages. J Invest Dermatol 1995: 105: 402-406.
8. Berne B, Ponten J, Ponten F. Decreased p53 expression in chronically sun-exposed human skin after topical photoprotection. Photodermatol Photoimmunol Photomed 1998: 14: 148-153.
9. The European Cosmetic Toiletry and Perfumery Association (COLIPA): SPF test method. May, 1994.
10. Japan Cosmetic Industry Association (JCIA): Measurements standard for UVA protection efficacy. Jan. 1, 1996.
11. Hausser I. Über spezifische Wirkungen des langwelligen ultravioletten Lichts auf die menschliche Haut. Strahlentherapie 1938: 62: 315-322.
12. Chardon A, Moyal D, Hourseau C. Persistent pigment-darkening response as a method for evaluation of ultraviolet A protection assays. In: Dekker M, ed. Sunscreens: development, evaluation and regulatory aspects. New York, Basel, Hong-Kong: 1997: 559-582.
13. Diffey BL, Robson J. A new substrate to measure sunscreen protection factors throughout the ultraviolet spectrum. J Soc Cosmet Chem 1989: 40: 127-133.
14. Ziegler A, Jonason AS, Lefell DJ et al. Sunburn and p53 in the onset of skin cancer. Nature 1994: 372: 773-776.
15. Campbell C, Quinn AG, Angus B, Farr PM, Rees JL. Wavelength specific patterns of p53 induction in human skin following exposure to UV irradiation. Cancer Res 1993: 53: 2697-2699.
16. Kastan MB, Oneyekwere O, Sidransky D, Vogelstein B, Graig R. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991: 51: 6304-6311.
17. Krekels G, Voorter C, Kuik F, Verhaegh M, Ramaekers F, Neumann M. DNA protection by sunscreens: p53-immunostaining. Eur J Dermatol 1997: 7: 259-262.
18. Burren R, Scaletta C, Frenk E, Panizzon RG, Applegate LA. Sunlight and carcinogenesis: expression of p53 and pyrimidine dimers in human skin following UVA I, UVA I+II and solar simulating radiation. Int J Cancer 1998: 76: 201-206.